Brief: Guardion Health Sciences Announces Quarterly Loss Per Share Of $0.19
16/08/2021 13:27
Aug 16 (Reuters) - Guardion Health Sciences Inc GHSI.O :
* GUARDION HEALTH SCIENCES ANNOUNCES FINANCIAL RESULTS FOR
THE
THREE MONTHS ENDED JUNE 30, 2021, INCLUDING $1,000,000+ OF SALES
FROM VIACTIV® PRODUCTS IN THE FIRST MONTH OF GUARDION’S
OWNERSHIP
* QUARTERLY LOSS PER SHARE $0.19
* QUARTERLY REVENUE ROSE 3 PERCENT TO $1.224 MILLION
Source text for Eikon: ID:nGNX7Cpv4n
Further company coverage: GHSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardion Health Sciences
See all newsBrief: Guardion Health Sciences Announces Termination Of CEO, Effective October 17
Brief: Guardion Health Sciences Announces Completion Of Sale Of Its Viactiv® Brand And Business To Doctor’S Best Inc. And Stockholder Approval Of Plan Of Liquidation And Dissolution
Brief: Guardion Health Sciences Announces Its Largest Stockholder Has Voted In Favor Of Proposals To Sell The Viactiv Business
Guardion Health Sciences Inc reports results for the quarter ended in March - Earnings Summary
Guardion Health Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview